MNX internals
| ||||||||||||||||||||||||||||
| Parent-child relations graph |
|
|||||||||||||||||||||||||||
| Identifier | Description |
|---|---|
CHEBI:82977 chebi:82977 FKRSSPOQAMALKA-CUPIEXAXSA-N | daclatasvir BMS 790052 BMS-790052 BMS790052 Dimethyl N,N'-(biphenyl-4,4'-diylbis{1H-imidazole-5,2-diyl-((2S)-pyrrolidine-2,1- diyl)((1S)-1-(1-methylethyl)-2-oxoethane-2,1-diyl)})dicarbamate methyl [(2S)-1-{(2S)-2-[4-(4'-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl]-1H-imidazol-4-yl}biphenyl-4-yl)-1H-imidazol-2-yl]pyrrolidin-1-yl}-3-methyl-1-oxobutan-2-yl]carbamate |
kegg.drug:D10065 keggD:D10065 FKRSSPOQAMALKA-CUPIEXAXSA-N | Daclatasvir (USAN) |
| hmdb:HMDB0250822 FKRSSPOQAMALKA-UHFFFAOYSA-N | Daclatasvir methyl N-(1-{2-[4-(4-{4-[2-(1-{2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl)-3H-imidazol-4-yl]phenyl}phenyl)-3H-imidazol-2-yl]pyrrolidin-1-yl}-3-methyl-1-oxobutan-2-yl)carbamate methyl N-(1-{2-[5-(4-{4-[2-(1-{2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl)-1H-imidazol-5-yl]phenyl}phenyl)-1H-imidazol-2-yl]pyrrolidin-1-yl}-3-methyl-1-oxobutan-2-yl)carbamate |
CHEBI:83801 chebi:83801 FKRSSPOQAMALKA-CUPIEXAXSA-P | daclatasvir(2+) daclatasvir cation |
keggD:M_D10065 | secondary/obsolete/fantasy identifier |